Literature DB >> 2427453

Functionally active monoclonal antibody that recognizes an epitope on the O side chain of Pseudomonas aeruginosa immunotype-1 lipopolysaccharide.

B J Stoll, M Pollack, L S Young, N Koles, R Gascon, G B Pier.   

Abstract

A murine monoclonal antibody (MAb) was prepared against Pseudomonas aeruginosa immunotype-1 (It-1) lipopolysaccharide (LPS). The MAb bound It-1 LPS in the enzyme-linked immunosorbent assay and in the immunodiffusion and immunoblotting assays, agglutinated and opsonized It-1 bacteria, and protected against challenge with live It-1 organisms in a murine burn infection model. All of these activities were immunotype specific. Correlation of the opsonic and protective properties of the MAb with its recognition site on the LPS O side chain confirmed that such immunotype-specific determinants are important targets for protective antibodies in Pseudomonas disease. The functional equivalence of this MAb and polyclonal antibodies from hyperimmune plasma underscores the therapeutic potential of single MAbs which recognize critical determinants in the LPS O side chain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427453      PMCID: PMC260844          DOI: 10.1128/iai.53.3.656-662.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  A quantitative immunochemical measure of the primary interaction between I BSA and antibody.

Authors:  R S FARR
Journal:  J Infect Dis       Date:  1958 Nov-Dec       Impact factor: 5.226

2.  Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections.

Authors:  O R Pavlovskis; M Pollack; L T Callahan; B H Iglewski
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

3.  Separation of leukocytes from blood and bone marrow. Introduction.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Isolation and characterization of antigenic components of a new heptavalent Pseudomonas vaccine.

Authors:  S Hanessian; W Regan; D Watson; T H Haskell
Journal:  Nat New Biol       Date:  1971-02-17

6.  Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors.

Authors:  L S Young; D Armstrong
Journal:  J Infect Dis       Date:  1972-09       Impact factor: 5.226

7.  Human immunity to Pseudomonas aeruginosa. II. Relationship between heat-stable opsonins and type-specific lipopolysaccharides.

Authors:  L S Young
Journal:  J Infect Dis       Date:  1972-09       Impact factor: 5.226

8.  Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model.

Authors:  D D Stieritz; I A Holder
Journal:  J Infect Dis       Date:  1975-06       Impact factor: 5.226

9.  Serological typing of Pseudomonas aeruginosa: use of commercial antisera and live antigens.

Authors:  C D Brokopp; R Gomez-Lus; J J Farmer
Journal:  J Clin Microbiol       Date:  1977-06       Impact factor: 5.948

10.  Quantitative granulocyte chemiluminescence in the rapid detection of impaired opsonization of Escherichia coli.

Authors:  P Stevens; L S Young
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

View more
  17 in total

1.  Effect of antiflagellar human monoclonal antibody on gut-derived Pseudomonas aeruginosa sepsis in mice.

Authors:  T Matsumoto; K Tateda; S Miyazaki; N Furuya; A Ohno; Y Ishii; Y Hirakata; K Yamaguchi
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

2.  Monoclonal antibodies delineate multiple epitopes on the O antigens of Salmonella typhi lipopolysaccharide.

Authors:  A Qadri; S K Gupta; G P Talwar
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

3.  Phage display and bacterial expression of a recombinant Fab specific for Pseudomonas aeruginosa serotype O6 lipopolysaccharide.

Authors:  N L Tout; J S Lam
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

4.  Isolation and characterization of monoclonal antibodies against alkaline phosphatase of Pseudomonas aeruginosa.

Authors:  M O Husson; C Mielcarek; F Gavini; C Caron; D Izard; H Leclerc
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

5.  Human monoclonal antibodies that protect mice against challenge with Pseudomonas aeruginosa.

Authors:  H J Zweerink; M C Gammon; C F Hutchison; J J Jackson; D Lombardo; K M Miner; J M Puckett; T J Sewell; N H Sigal
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

6.  Effects of the combination of lipopolysaccharide-specific monoclonal antibodies and sparfloxacin against Pseudomonas aeruginosa pneumonia in neutropenic mice.

Authors:  K Oishi; F Sonoda; A Iwagaki; S Kobayashi; T Nagatake; K Matsumoto
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

7.  Role of antibodies in the opsonization of Yersinia spp.

Authors:  R Tertti; E Eerola; K Granfors; R Lahesmaa-Rantala; K Pekkola-Heino; A Toivanen
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

8.  A protective human monoclonal antibody directed to the outer core region of Pseudomonas aeruginosa lipopolysaccharide.

Authors:  M Terashima; I Uezumi; T Tomio; M Kato; K Irie; T Okuda; S Yokota; H Noguchi
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

9.  Serum antibody response to Pseudomonas aeruginosa antigens during corneal infection.

Authors:  M J Preston; J M Berk; L D Hazlett; R S Berk
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

10.  In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharide.

Authors:  G B Pier; D Thomas; G Small; A Siadak; H Zweerink
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.